A new blood test may help people detect Alzeimher’s more easily compared to tests currently in use.
Researchers at the University of Pittsburgh have devised a new lab test, which could potentially identify people at risk of developing the neurodegenerative disease. The test, known as SOBA, was able to flag risk patterns associated with Alzeimher’s amongst healthy participants who did not experience cognitive decline.
The news follows the development of a ground-breaking drug for the disease earlier this year. Scientists believe that the trial drug, Lecanemab, could help slow the progress of dementia amongst patients in the early stages of the disease.
